Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.73 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.73 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.73 |
| ▸ | HTR2A | P28223 | 1/20 | 0.73 |
| ▸ | HTR2C | P28335 | 1/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | HRH1 | P35367 | 1/20 | 0.73 |
| ▸ | DRD3 | P35462 | 1/20 | 0.73 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.73 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.73 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.63 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.60 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1943942 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1115851 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| Arundic Acid SCHEMBL277260 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL3630645 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL2489255 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1115797 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL15499898 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL432094 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1115939 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1115977 | 1.00 | CHRM1 (0.73) | CHRM1AKR1A1CHRM3HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100430364-C | Preparation method of (2R) -2-propyl octanoic acid | ONO PHARMACEUTICAL CO (JP) | 2008-11-05 | — | — | CN | claimed |
| CN-101100422-A | Process for the preparation of (2R)-2-propyloctanoic acid | ONO PHARMACEUTICAL CO (JP) | 2008-01-09 | — | — | CN | claimed |
| US-20070043114-A1 | Nerve regeneration promoters | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-02-22 | — | — | US | claimed |
| EP-1685832-A1 | NERVE REGENERATION PROMOTERS | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-08-02 | — | — | EP | claimed |
| US-10000432-B2 | Processes for the synthesis of chiral 1-alkanols | PURDUE RESEARCH FOUNDATION (US) | 2018-06-19 | — | — | US | disclosed |
| US-10000432-B2 | Processes for the synthesis of chiral 1-alkanols | PURDUE RESEARCH FOUNDATION (US) | 2018-06-19 | — | — | US | disclosed |
| EP-3094613-A1 | PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS | Purdue Research Foundation, Inc. (US) | 2016-11-23 | — | — | EP | disclosed |
| US-20160332940-A1 | PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS | PURDUE RESEARCH FOUNDATION (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160332940-A1 | PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS | PURDUE RESEARCH FOUNDATION (US) | 2016-11-17 | — | — | US | disclosed |
| WO-2015106045-A1 | PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS | PURDUE RESEARCH FOUNDATION (US) | 2015-07-16 | — | — | WO | disclosed |
| US-8569058-B2 | Nerve regeneration promoters | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-10-29 | — | — | US | disclosed |
| EP-1741697-B1 | CRYSTAL COMPRISING (2R)-2-PROPYLOCTANOIC ACID AND DIBENZYLAMINE | ONO PHARMACEUTICAL CO (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-20060135802-A1 | Process for producing (2r)-2-propyloctanoic acid and intermediate therefor | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-06-22 | — | — | US | disclosed |
| CN-1144796-C | Intermediates and process for preparation of optically active octanoic acid derivs. | СҰҩƷ��ҵ��ʽ���� | 2004-04-07 | — | — | CN | disclosed |
| EP-1078921-B1 | NOVEL INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF OPTICALLY ACTIVE OCTANOIC ACID DERIVATIVES | ONO PHARMACEUTICAL CO (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-6392073-B1 | IMPROVED OPTICAL PURITY OVER RECRYSTALLIZATION METHOD; 2.10 CAMPHORSULTAM DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-05-21 | — | — | US | disclosed |
| US-20020028947-A1 | Novel intermediates and processes for the preparation of optically active octanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2002-03-07 | — | — | US | disclosed |
| US-6333415-B1 | N-(2S-(2-(PROPENYL OR PROPYNYL OR PROPYL)) OCTANOYL) (1S)-(-)-2,10-CAMPHORSULTAM, TO PREPARE 2S-(2-(PROPENYL OR PROPYNYL OR PROPYL)) OCTANOIC ACID, | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-12-25 | — | — | US | disclosed |
| CN-1309652-A | Intermediates and process for preparation of optically active octanoic acid derivs. | ONO PHARMACEUTICAL CO (JP) | 2001-08-22 | — | — | CN | disclosed |
| EP-1078921-A1 | NOVEL INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF OPTICALLY ACTIVE OCTANOIC ACID DERIVATIVES | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043114-A1 | Nerve regeneration promoters | BDNF, NGF, GAP43 | CHRM1 2671/4885AKR1A1 2042/4885CHRM3 2784/4885 |
| US-20160332940-A1 | PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS | CYP51A1, ALKBH3, ALKBH1 | CHRM1 815/4885AKR1A1 134/4885CHRM3 1892/4885 |
| US-20020028947-A1 | Novel intermediates and processes for the preparation of optically active octanoic acid derivatives | PDE6H, PDE6C, PDE6D | CHRM1 1065/4885AKR1A1 391/4885CHRM3 280/4885 |
| US-10000432-B2 | Processes for the synthesis of chiral 1-alkanols | CYP51A1, ALKBH3, ALKBH1 | CHRM1 815/4885AKR1A1 134/4885CHRM3 1892/4885 |
| US-20060135802-A1 | Process for producing (2r)-2-propyloctanoic acid and intermediate therefor | CYP51A1, POR, GRHPR | CHRM1 2724/4885AKR1A1 61/4885CHRM3 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.